Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasuo Yanagihara is active.

Publication


Featured researches published by Yasuo Yanagihara.


Clinical and Experimental Immunology | 1999

Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)

Yasuo Yanagihara; K Shiozawa; Masaaki Takai; Masahisa Kyogoku; S Shiozawa

The number of NK T cells was measured in relation to the Th1/Th2 imbalance observed in RA. Peripheral blood samples of patients with RA (n = 60) and healthy controls (n = 36) were stained with anti‐NK receptor 1A (anti‐NKR‐P1A), anti‐CD56, and anti‐CD3 MoAbs, and examined by three‐colour flow cytometry. NK T (NKR‐P1A+CD3+) cells in the peripheral blood were decreased in RA compared with the controls: 25 ± 20/μl versus 143 ± 53/μl (P < 0.0001). CD56+CD3+ cells were also decreased in RA: 60 ± 46/μl versus 116 ± 54/μl (P < 0.0001). The decrease was significant when adjusted to the number of total lymphocytes (P < 0.0001) or NK (CD56+CD3−) cells (P < 0.0001), and showed no correlation with age, sex, disease duration, disease activity, functional class, x‐ray stage, drug treatment, joint score, grip strength, C‐reactive protein, rheumatoid factor or erythrocyte sedimentation rate of the patients. The results show that the levels of NK T cells are depressed in the peripheral blood of patients with RA, suggesting that the measurement of NK T cells in peripheral blood may have clinical importance for a Th1‐type autoimmune disease like RA.


Archive | 1985

Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Journal of Biochemistry | 1993

3-Cyano-2, 6-Dihydroxypyridine (CNDP), a New Potent Inhibitor of Dihydrouracil Dehydrogenase

Kunihiko Tatsumi; Takeshi Yamauchi; Kunihiko Kiyono; Kazumasa Kishi; Yasuo Yanagihara; Takeshi Imaoka; Teruhisa Kawaguchi; Masanori Kubo


Archive | 1987

IL-1 beta derivatives and drugs

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Haitsu Soreiyu Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1987

IL-1alpha derivatives and drugs

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Sanraunjihausu Hong; Kazuyoshi Haitsu Soreiyu Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 2007

Stat3/5 activation inhibitor

Kazuo Sekiguchi; Takashi Suzuki; Yutaka Ohbuchi; Mitsuhiro Okuno; Naoto Ohi; Kenji Ohnishi; Masaaki Motoyama; Kenji Yoshida; Takeshi Kodama; Kazuhisa Sugiyama; Seiji Akamatsu; Kunihiko Kiyono; Yasuo Yanagihara; Takashi Watanabe; Kazuhiko Hayashi; Hideo Tanaka; Takumi Sumida


Archive | 2011

DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS

Hideki Takasu; Shigekazu Fujita; Shinya Ohtsuka; Toshiyuki Hirose; Yosuke Sato; Satoshi Yamada; Keisuke Miyajima; Koji Sakai; Yutaka Kojima; Kazuo Sekiguchi; Yasuo Yanagihara; Takashi Suzuki; Hideo Tanaka; Kazuhisa Sugiyama; Mitsuhiro Okuno; Takumi Sumida


Archive | 1987

IL-1α derivatives and drugs

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1993

Medical uses of IL-1 beta.

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Haitsu Soreiyu Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1995

Methods of use of IL-1α

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai

Collaboration


Dive into the Yasuo Yanagihara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge